Genetic Testing: a Catch-22 for the Insurance Industry?

Despite all testing, it is still a challenge to determine how the many complex parts of the genome work together in human health and disease. This article is an extract of our 2018 CH&Co. Fintank yearly publication on Innovation for Financial Services.

Scroll to Top